Faculty profile

Joyce Rauch

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Joyce Rauch

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
9 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Animal Models Apoptosis Autoantibodies Cell Death Human Cells Immune Cells Inflammation Necroptosis

Latest papers

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.
Journal of autoimmunity · 2026
Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus model.
Journal of translational autoimmunity · 2026 · senior author
RIPK3 impacts antibody generation in an induced model of murine lupus through mechanisms other than necroptosis and antigen presentation.
Frontiers in immunology · 2025 · senior author

All 24 publications

Latest funding

Investigating a Novel Cross-DNA Virus as a Pathogenic Trigger of Localized Scleroderma
SSHRC · 2024 · Co-investigator
$125,000
Mapping anti-mitochondrial antibodies in systemic lupus erythematosus
CIHR · 2018 · Co-investigator
$416,280
Targeting RIPK3 as a key regulator in the development of SLE
CIHR · 2018 · Nominated PI
$745,876

All 5 grants and awards

24 publications.

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.

Zhao N, Rochepeau A, Sauvé S, Mendel A, Vinet E, Verner MA, Rauch J, Pineau CA, Lukasa L, Grenier LP, Kalache F, Bernatsky S

Journal of autoimmunity2026

DOI: 10.1016/j.jaut.2026.103636 PMID: 42753309

Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus model.

Levine JS, Pilon C, Subang R, Salem D, Lonina E, Qureshi ST, Fonseca GJ, Gros P, Rauch J

Journal of translational autoimmunity2026Senior author

DOI: 10.1016/j.jtauto.2026.100351 PMID: 41704663

RIPK3 impacts antibody generation in an induced model of murine lupus through mechanisms other than necroptosis and antigen presentation.

Pilon C, Lonina E, Levine JS, Lesage S, Rauch J

Frontiers in immunology2025Senior author

DOI: 10.3389/fimmu.2025.1506124 PMID: 41098721

Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.

Sinha U, Setty S, Pilon C, Brown JJ, Ruiz MA, Ren G, Rauch J, Saraf SL, Levine JS

British journal of haematology2025

DOI: 10.1111/bjh.19972 PMID: 39748216

Vascular injury derived apoptotic exosome-like vesicles trigger autoimmunity.

Juillard S, Karakeussian-Rimbaud A, Normand MH, Turgeon J, Veilleux-Trinh C, C Robitaille A, Rauch J, Chruscinski A, Grandvaux N, Boilard É, Hébert MJ, Dieudé M

Journal of translational autoimmunity2024

DOI: 10.1016/j.jtauto.2024.100250 PMID: 39286649

Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps.

Kmeťová K, Lonina E, Yalavarthi S, Levine JS, Hoy CK, Sarosh C, Gockman K, Morris AE, Tambralli A, Madison JA, Zuo Y, Subang R, Rauch J, Knight JS

Clinical immunology (Orlando, Fla.)2023

DOI: 10.1016/j.clim.2023.109714 PMID: 37527733

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease.

Rivera CR, Srisuwananukorn A, Bajwa RJ, Gordeuk VR, Rauch J, Levine JS, Saraf SL

EJHaem2023

DOI: 10.1002/jha2.643 PMID: 36819151

Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study.

Mendel A, Fritzler MJ, St-Pierre Y, Rauch J, Bernatsky S, Vinet É

Research and practice in thrombosis and haemostasis2023

DOI: 10.1016/j.rpth.2023.100041 PMID: 36644653

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.

de França NR, Ménard HA, Lora M, Zhou Z, Rauch J, Hitchon C, Andrade LEC, Colmegna I

Arthritis research & therapy2022

DOI: 10.1186/s13075-021-02698-2 PMID: 35027076

FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.

Melki I, Allaeys I, Tessandier N, Mailhot B, Cloutier N, Campbell RA, Rowley JW, Salem D, Zufferey A, Laroche A, Lévesque T, Patey N, Rauch J, Lood C, Droit A, McKenzie SE, Machlus KR, Rondina MT, Lacroix S, Fortin PR, Boilard E

Blood2020

DOI: 10.1182/blood.2020004974 PMID: 33331924

Something wrong or missing on this profile? Suggest a correction

Joyce Rauch

Research

Latest papers

Latest funding

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.

Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus model.

RIPK3 impacts antibody generation in an induced model of murine lupus through mechanisms other than necroptosis and antigen presentation.

Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.

Vascular injury derived apoptotic exosome-like vesicles trigger autoimmunity.

Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps.

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease.

Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study.

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.

FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.

Investigating a Novel Cross-DNA Virus as a Pathogenic Trigger of Localized Scleroderma

Mapping anti-mitochondrial antibodies in systemic lupus erythematosus

Targeting RIPK3 as a key regulator in the development of SLE

Induction of a murine model of anti-phospholipid syndrome

Induction of a murine model of anti-phospholipid syndrome

Frequent collaborators

Eric Boilard

Arielle Mendel

Arielle Mendel

Sasha Bernatsky

Sasha Bernatsky

Sylvie Lesage

Lihi Eder

Evelyne Vinet

Carol Hitchon

Evelyne Vinet

Arnaud Droit

Andrzej Chruscinski

Martin Pelletier

Philippe Gros

Lawrence Joseph

Maziar Divangahi

Steve Lacroix

Joyce Rauch

Research

Latest papers

Latest funding

Serum perfluorooctane sulfonate and perfluorooctanoic acid concentrations and longitudinal systemic lupus outcomes.

Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus model.

RIPK3 impacts antibody generation in an induced model of murine lupus through mechanisms other than necroptosis and antigen presentation.

Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.

Vascular injury derived apoptotic exosome-like vesicles trigger autoimmunity.

Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps.

Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease.

Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study.

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.

Fc&#x3b3;RIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.

Investigating a Novel Cross-DNA Virus as a Pathogenic Trigger of Localized Scleroderma

Mapping anti-mitochondrial antibodies in systemic lupus erythematosus

Targeting RIPK3 as a key regulator in the development of SLE

Induction of a murine model of anti-phospholipid syndrome

Induction of a murine model of anti-phospholipid syndrome

Frequent collaborators

Eric Boilard

Arielle Mendel

Arielle Mendel

Sasha Bernatsky

Sasha Bernatsky

Sylvie Lesage

Lihi Eder

Evelyne Vinet

Carol Hitchon

Evelyne Vinet

Arnaud Droit

Andrzej Chruscinski

Martin Pelletier

Philippe Gros

Lawrence Joseph

Maziar Divangahi

Steve Lacroix

FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.